As a part
of the Market Access Team he/she takes a key role in the development and
communication of cost‐benefit arguments for our drugs.
He/she liaises with our worldwide network of Health Economy specialists and keeps track of the actual scientific developments to secure optimal knowledge transfer.
He/she supports our internal product teams and sales organization with value arguments and pharma economic evaluations.
He/she provides support to all departments on pricing and reimbursement related matters.
He/she takes a key role in the development of pricing and reimbursement dossiers and interacts with internal and external stakeholders to collect information necessary for submissions.
He/she initiates and manages projects to better understand cost implications and the value of medicines.
He/she provides support to improve the understanding of our key stakeholders with regard to cost‐value arguments.
degree in life sciences (MD or PhD)
Profound scientific or economic background with the ability and interest for interdisciplinary questions.
Further education in health economy or public health and/or knowledge of the Swiss healthcare system is an asset.
Ability to critically interpret and use scientific literature.
Excellent analytical skills and the ability to identify key strategic issues.
Ability to establish and maintain a good professional network within and outside the company.
Motivation to work in a small high performance team with a broad product portfolio.
Ability to manage multiple tasks and complex issues.
Excellent German and English language skills. French is an asset.
High degree of self‐motivation and ability to work in a team.
Good communication and negotiation skills and trust building appearance.
Excellent interpersonal skills and ability to work in a complex matrix organization
Smart well-educated scientists with an open mind and willingness to learn.
Janssen-Cilag Switzerland (7325)